Sienna Rights Issue Closing 9th January 2017

23-Dec-2016 Sienna Cancer Diagnostics Limited advises that the closing date for the current Rights Issue offer to shareholders is 9 January 2017.

The Rights Issue is being undertaken on the basis of 1 new share for every 4.26 ordinary shares held by eligible shareholders on the record date (17 November 2016), at an issue price of $0.17 per ordinary share.  For every three (3) new ordinary shares subscribed for, one (1) option will be granted, exercisable at $0.22.  These options vest on 2 April 2018 and remain exercisable for 6 months.

The company is pleased with the response to the Rights Issue to date, and reserves the right to place any shortfall.

Parties interested in investing should direct their enquiries to CFO and Company Secretary, Mr Tony Di Pietro via email at


No Very

Captcha Image

Sign up to our newsletter

Contact Sienna

Sienna Cancer Diagnostics

1 Dalmore Drive Scoresby VIC 3179 Australia

Telephone +61 3 8288 2141 Facsimile +61 3 8288 2059